PD-1 Antikörper
Kurzübersicht für PD-1 Antikörper (ABIN6253466)
Target
Alle PD-1 (PDCD1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
- 
    
- 
                                            
Verwendungszweck
 - anti-PD-1 (mouse), mAb (blocking) (1H10)
 - 
                                            
Produktmerkmale
 - Monoclonal Antibody. Recognizes mouse PD-1 (CD279). Does not cross-react with human PD-1d. Isotype: Rat IgG2akappa. Clone: 1H10. Applications: FACS, FUNC (Blocking). Liquid. In PBS containing 0.02 % sodium azide. CD279 (Programmed Cell Death Protein 1, PD-1) is a type I transmembrane protein belonging to the CD28/CTLA-4 family of immunoreceptors that mediate signals for regulating immune responses. Members of the CD28/CTLA-4 family have been shown to either promote T cell activation (CD28 and ICOS) or downregulate T cell activation (CTLA-4 and PD-1). CD279 is expressed on activated T cells, B cells, myeloid cells and on a subset of thymocytes. In vitro, ligation of CD279 inhibits TCR-mediated T cell proliferation and production of IL-1, IL-4, IL-10 and IFN-gamma. In addition, CD279 ligation also inhibits BCR mediated signaling. CD279 deficient mice have a defect in peripheral tolerance and spontaneously develop autoimmune diseases.
 - 
                                            
Reinheit
 - >95 % (SDS-PAGE)
 - 
                                            
Endotoxin-Niveau
 - <0.01EU/μg purified protein (LAL test, Lonza).
 - 
                                            
Immunogen
 - Mouse PD-1 transfected cell line.
 - 
                                            
Isotyp
 - IgG2a kappa
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Applikationshinweise
 - Optimal working dilution should be determined by the investigator.
 - 
                                            
Beschränkungen
 - Nur für Forschungszwecke einsetzbar
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Liquid
 - 
                                            
Konzentration
 - Lot specific
 - 
                                            
Buffer
 - Liquid. In PBS containing 0.02 % sodium azide.
 - 
                                            
Konservierungsmittel
 - Sodium azide
 - 
                                            
Vorsichtsmaßnahmen
 - This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
Handhabung
 - After opening, prepare aliquots and store at -20 °C. Avoid freeze/thaw cycles.
 - 
                                            
Lagerung
 - 4 °C,-20 °C
 - 
                                            
Informationen zur Lagerung
 - 
                        
Short Term Storage: +4°C
Long Term Storage: -20°C
Use & Stability: Stable for at least 1 year after receipt when stored at -20°C.
 
 - 
                                            
 - 
    
- PD-1 (PDCD1) (Programmed Cell Death 1 (PDCD1))
 - 
                                            
Andere Bezeichnung
 - PD-1
 - 
                                            
Hintergrund
 - 
                        
Alternate Names/Synonyms: CD279, Programmed Cell Death Protein 1
Product Description: CD279 (Programmed Cell Death Protein 1, PD-1) is a type I transmembrane protein belonging to the CD28/CTLA-4 family of immunoreceptors that mediate signals for regulating immune responses. Members of the CD28/CTLA-4 family have been shown to either promote T cell activation (CD28 and ICOS) or downregulate T cell activation (CTLA-4 and PD-1). CD279 is expressed on activated T cells, B cells, myeloid cells and on a subset of thymocytes. In vitro, ligation of CD279 inhibits TCR-mediated T cell proliferation and production of IL-1, IL-4, IL-10 and IFN-gamma. In addition, CD279 ligation also inhibits BCR mediated signaling. CD279 deficient mice have a defect in peripheral tolerance and spontaneously develop autoimmune diseases.
 - 
                                            
NCBI Accession
 - NP_005009
 - 
                                            
Pathways
 - Cancer Immune Checkpoints
 
Target
 -